Infliximab 57894-0160-01

Package NDC

57894-0160-01

Manufacturer: Janssen Biotech, Inc.
Dosage Form: Injection, Powder, Lyophilized, For Solution
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: October 5, 2021
Listing Expires: December 31, 2027
Application: BLA103772

Need to source Infliximab? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Infliximab	100 mg/10mL

Drug Class

Tumor Necrosis Factor Blocker [EPC]Tumor Necrosis Factor Blocker [EPC]Tumor Necrosis Factor Receptor Blocking Activity [MoA]

Selected Package

57894-0160-01Selected

1 VIAL, SINGLE-USE in 1 BOX (57894-160-01) / 10 mL in 1 VIAL, SINGLE-USE